News Search Results
Sep 29, 2025, 11:45 ET Oilfield Service Equipment Market to reach US$36,874.37 million by 2031 at CAGR of 5.39% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.
More news about: The Insight Partners
Sep 29, 2025, 11:15 ET Synthetic Ester Lubricants Market To Reach US$5.06 Billion By 2031, at CAGR of 5.4%| The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.
More news about: The Insight Partners
Sep 29, 2025, 11:01 ET White Fused Alumina Market To Reach US$915.39 Million By 2031 at of 5.1% Amid Expansion of End-Use Industries | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.
More news about: The Insight Partners
Sep 29, 2025, 10:45 ET Laboratory Equipment Market is expected to generate a revenue of USD 41.13 Billion by 2032, Globally, at 13.40% CAGR: Verified Market Research®
growth fueled by advancements in life sciences, rising demand for clinical diagnostics, and increased R&D investments across pharmaceuticals and biotechnology. However, high equipment costs and stringent regulatory approvals pose restraints. Additionally, the growing need for automation, precision testing,
More news about: Verified Market Research
Sep 29, 2025, 10:45 ET Aluminum Formwork Market To Reach US$8,181.93 Million By 2031 at CAGR of 5.6% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.
More news about: The Insight Partners
Sep 29, 2025, 10:30 ET Practice Management Systems Market is Projected to Reach US$36.33 billion at CAGR of 9.3% Amid Need for Operational Efficiency & Automation | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.
More news about: The Insight Partners
Sep 29, 2025, 10:15 ET Cross Belt Sorters Market is projected to reach US$3.39 billion by 2031, registering a strong CAGR of 6.07% Amid Explosive Growth of E‑commerce & Logistics Needs | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.
More news about: The Insight Partners
Sep 29, 2025, 10:01 ET Tactical Communication Market To Reach US$44,834.46 Million By 2031 At Register A CAGR Of 11.00% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.
More news about: The Insight Partners
Sep 29, 2025, 10:01 ET Crypto Phone Market Is Projected To Reach US$9.18 Billion By 2031, Registering a Strong CAGR of 21.5% Amid Rising Cybersecurity Threats And Data Breaches | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.
More news about: The Insight Partners
Sep 29, 2025, 08:31 ET Alfa Laval backs transatlantic biotech collaboration to accelerate food innovation
for a growing global population while minimizing environmental impact. North Carolina is recognized as a leading hub for biotechnology with a robust ecosystem of research, innovation and skilled talent. Its unique combination of academic excellence and industrial infrastructure
More news about: Alfa Laval
Sep 29, 2025, 08:30 ET Solutions For Recombinant Protein Expression, Upcoming Webinar Hosted by Xtalks
TORONTO, Sept. 29, 2025 /PRNewswire/ -- Recombinant protein expression is a cornerstone of modern biotechnology, fueling advances in drug development, molecular biology research and industrial biocatalysis. Challenges with inefficient expression or the accumulation
More news about: Xtalks
Sep 29, 2025, 08:30 ET New medical writing service QInscribe reduces the time to generate a draft clinical study report (CSR) by 90% with generative AI solution
quality regulatory documents at record breaking production times with advanced AI-supported workflows. With pharmaceutical and biotechnology companies under increasing pressure to streamline regulatory submissions and improve document consistency, QInscribe steps into the market with
More news about: QInscribe
Sep 29, 2025, 08:30 ET Oncolytics Biotech® Announces Update for Potential First-Line Pancreatic Cancer Registration Study
About Oncolytics Biotech Inc. Oncolytics is a clinical-stage biotechnology company developing pelareorep, an investigational intravenously delivered double-stranded RNA immunotherapeutic agent. Pelareorep has demonstrated
More news about: Oncolytics Biotech® Inc.
Sep 29, 2025, 08:00 ET BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement ("APA")
acquiring the entire portfolio of assets and intellectual property based on the DPX™ immune educating platform technology developed by Canadian biotechnology company, IMV Inc.
More news about: BioVaxys Technology Corp.
Sep 29, 2025, 08:00 ET Coya Therapeutics Announces Completion of Patient Enrollment of an Investigator-Initiated, Open-Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Patients with Mild to Moderate Frontotemporal Dementia
Sept. 29, 2025 /PRNewswire/ -- Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with neurodegenerative disorders, announces completion
More news about: Coya Therapeutics, Inc.
Sep 29, 2025, 08:00 ET CPDC Launches Cadena Research, a Radiopharmaceutical Preclinical CRO
expertise in radiochemistry, imaging, preclinical studies, and regulatory strategy. Cadena Research's clients include startups, academic innovators, biotechnology and large pharmaceutical companies internationally, seeking a trusted partner to navigate the complexities of radiopharmaceutical development. For
More news about: Centre for Probe Development and Commercialization (CPDC)
Sep 29, 2025, 07:05 ET REGENXBIO Announces Presentation at the World Muscle Society
NAVXpress® suspension-based platform process. ABOUT REGENXBIO Inc.REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered
More news about: REGENXBIO Inc.
Sep 29, 2025, 06:48 ET Global Hydrogen Generation Market Size & Share to Surpass $322.3 Billion by 2035, Growing at a CAGR 7.45% | Driving Industrial, Mobility, and Green Energy Transformation
market research reports and actionable intelligence across healthcare, biotechnology, and advanced cell therapies. Our globally recognized insights empower stakeholders to make informed decisions, anticipate trends, and capitalize
More news about: Vantage Market Research
Sep 29, 2025, 06:30 ET Diagonal Therapeutics to Present New Preclinical Data Demonstrating Disease-Modifying Potential of DIAG723 in Pulmonary Arterial Hypertension at 2025 ERS Congress
Diagonal Therapeutics, a biotechnology company focused on correcting dysregulated signaling with clustering antibodies that address the underlying cause of intractable genetic diseases,
More news about: Diagonal Therapeutics
Sep 29, 2025, 06:00 ET AllRock Bio Presents Phase 1 Data for Lead Program, ROC-101, at the ERS Congress
NATICK, Mass., Sept. 29, 2025 /PRNewswire/ -- AllRock Bio, Inc., a clinical stage biotechnology company focused on advancing impactful therapies for cardiopulmonary and fibrotic diseases, today announced encouraging Phase 1 data for its first-in-class
More news about: AllRock Bio
Sep 29, 2025, 06:00 ET Bridge to Life Appoints David Castiglioni as Chief Commercial Officer to Head Global Commercial Operations and Lead the U.S. Commercialization of VitaSmart™
Mr. Castiglioni brings nearly three decades of leadership experience in healthcare, medtech, and biotechnology. He has a proven record of building high-performing commercial teams, scaling early-stage ventures into global businesses, and driving transformative
More news about: Bridge to Life, Ltd.
Sep 29, 2025, 04:52 ET VC Community Convenes in Qingdao to Explore New Financial Landscape Amid 2025 Qingdao Venture Capital Conference
intelligence emerging as the most promising field. Specifically, intelligent and advanced manufacturing, artificial intelligence and big data, and biotechnology stand out as the most attractive target for investment. The white paper predicts that the future growth of the VC/PE industry in China will feature
More news about: 2025 Qingdao Venture Capital Conference
Sep 29, 2025, 01:01 ET Lupin Strengthens its Global Specialty Ophthalmology Business with Acquisition of VISUfarma from GHO Capital
products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position
More news about: Lupin Limited
Sep 29, 2025, 00:45 ET Lupin Strengthens its Global Specialty Ophthalmology Business with Acquisition of VISUfarma from GHO Capital
products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position
More news about: Lupin Limited
Sep 28, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers - UNCY
[Click here for information about joining the class action] Unicycive is a clinical-stage biotechnology company that identifies, develops, and commercializes therapies to address unmet medical needs in the U.S. The Company is developing, among other
More news about: Pomerantz LLP